EGFR and non-small cell lung carcinoma: Overall, roughly one-third of non-small cell lung cancers (NSCLC) have a mutation in the epidermal growth factor receptor (EGFR) gene, although distinct geographical differences have been reported, with the lowest in Europe and the highest in Asia (1).